SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-10-053174
Filing Date
2010-10-21
Accepted
2010-10-21 17:00:44
Documents
9
Period of Report
2010-10-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-19653_18k.htm 8-K 32934
2 EX-99.1 a10-19653_1ex99d1.htm EX-99.1 10468
3 EX-99.2 a10-19653_1ex99d2.htm EX-99.2 37811
4 EX-99.3 a10-19653_1ex99d3.htm EX-99.3 129819
5 GRAPHIC g196531moi001.jpg GRAPHIC 1766
6 GRAPHIC g196531moi002.jpg GRAPHIC 4640
7 GRAPHIC g196531mmi001.jpg GRAPHIC 1133
8 GRAPHIC g196531mmi002.gif GRAPHIC 1973
9 GRAPHIC g196531mmi003.gif GRAPHIC 2625
  Complete submission text file 0001104659-10-053174.txt   230085
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19700 | Film No.: 101135495
SIC: 2834 Pharmaceutical Preparations